The team

Woan KV, Kim H, Bjordahl R, Davis ZB, Gaidarova S, Goulding J, Hancock B, Mahmood S, Abujarour R, Wang H, Tuininga K, Zhang B, Wu CY, Kodal B, Khaw M, Bendzick L, Rogers P, Ge MQ, Bonello G, Meza M, Felices M, Huffman J, Dailey T, Lee TT, Walcheck B et al. (2021)
Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy
Cell Stem Cell (in press)
DOI 10.1016/j.stem.2021.08.013, PubMed 34525347

Lachota M, Lennikov A, Malmberg KJ, Zagozdzon R (2021)
Bioinformatic Analysis Reveals Central Role for Tumor-Infiltrating Immune Cells in Uveal Melanoma Progression
J Immunol Res, 2021, 9920234
DOI 10.1155/2021/9920234, PubMed 34195299

Chiu E, Felices M, Cichocki F, Davis Z, Wang H, Tuninga K, Vallera DA, Lee T, Bjordahl R, Malmberg KJ, Valamehr B, Miller JS (2021)
Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C⁺ NK cells to target myeloid leukemia
Mol Ther (in press)
DOI 10.1016/j.ymthe.2021.06.018, PubMed 34174441